Jury

Mandi Fine

CEO

Fine Healthcare

JOHANNESBURG, SOUTH AFRICA // Mandi Fine is the CEO and Founder of renowned strategic its subsidiary, Fine Group (specialising in strategic communications). Mandi is widely recognised as a thoughtleader and expert in the healthcare communications space in South Africa, Africa and beyond. Mandi is passionate about CSI and achieving better healthcare for all South Africans.

Mandi Fine holds an MSc in Nutrition and Neuroscience from Wits University, where she has published numerous international clinical papers from her healthcare communication, working for Harrison and Star Omnicom, a specialised healthcare communications agency based in New York. Here Fine serviced large multinational pharmaceutical companies based in New Jersey. Mandi returned to South Africa in 1999 to launch Fine Healthcare. Fine Healthcare was started within the agency, and has since become recognised as the South African leader in healthcare communications. Fine Healthcare has received numerous local and international awards for creativity and innovation. Mandi consults to Marketing Directors & CEO’s of healthcare corporations both locally and abroad. She has been responsible for some of the country’s most successful healthcare brand launches including Viagra, Celebrex, Valdoxane, Life Healthcare and many others. In addition, Fine has a special interest in aiding patient compliance to medication, and liberating medical information having pioneered some of the first mobile phone compliance tools and medical apps developed globally. While Fine Healthcare continues to move from strength to strength, Mandi, a mother of two sons, still finds time to give back to the community. She is a former board member of Ikageng Itireleng Aids Ministry, a Soweto-based, NGO that supports over 2000 orphaned and vulnerable children who live in child-headed households. Fine Healthcare is recognised in SA as a leader in Corporate Social Investment. The work that they do with Ikageng Itireleng has been acknowledged and awarded by government and industry alike.